Tumor-Lymph Node Mapping
Recruiting
Observational Study
Pediatric Solid Tumors
Rhabdomyosarcoma
Sarcoma
Germ Cell Tumor
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Month – 17
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10 (estimated)
- Sponsor
- University of Rochester · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling.
This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the tim…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Any pediatric patient (under the age of 18 years) being treated at the University of Rochester Medical Center, Department of Surgery.
* Diagnosed with pediatric solid tumor
* Scheduled to undergo lymph node sampling as part of their clinical management.
Exclusion Criteria:
*…
Contacts